Holen Sie sich die Stockscreener-App
9.27
1.59%
-0.15
Vorhandelsmarkt:
9.30
0.03
+0.32%
Anteris Technologies Global Corp Aktie (AVR) Neueste Nachrichten
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued Clinical InvestmentCore Business Growth - newsline.com
Funds from operations of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies (AVR) director exercises 17,580 RSUs into common shares - Stock Titan
Anteris (AVR) CFO exercises options, delivers 39,595 shares for taxes - Stock Titan
AVR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: EPS Misses Estimates Significantly Amid Continued R&D InvestmentGAAP Earnings Report - newsline.com
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - marketscreener.com
Update: Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - Moomoo
Anteris Advances DurAVR Program Through ASX 300 Expansion - Kalkine Media
Anteris Technologies Global Corp Gets French Regulatory Clearance For Duravr Paradigm Global Pivotal Trial - TradingView
Anteris Wins French Clearance to Expand Global DurAVR Heart Valve Trial - TipRanks
France clearance marks key milestone for Anteris' pivotal PARADIGM Trial - Yahoo Finance
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment - marketscreener.com
Anteris Technologies Global Corp. Receives French Regulatory Clearance for Duravr Transcatheter Heart Valve Global Pivotal Trial - marketscreener.com
Anteris Technologies Global Receives French Regulator's Approval for DurAVR Trial in Aortic Stenosis - marketscreener.com
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance - The Manila Times
Why Is Anteris Technologies (ASX: AVR) Trading Near a 52-Week High? - Kalkine
Insider Scoop: Major Director Buy Signals Fresh Confidence in Anteris Technologies Global Corp. - TipRanks
Anteris Director Susan Knight Buys First Stake in Company - TipRanks
Anteris Investors Shift From ASX CDIs to Nasdaq Common Stock in May - TipRanks
Anteris Technologies (AVR) director purchases 11,000 shares in open market - Stock Titan
Why Is Anteris Technologies Global Corp. (AVR) Stock Up Today? - Meyka
Anteris Options Lapse, Trimming Potential Future Dilution - TipRanks
Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL), Cogent Biosciences (COGT) and Anteris Technologies Global Corp. (AVR) - The Globe and Mail
Anteris (NASDAQ: AVR) signs $250M at-the-market sales agreement with TD Cowen - Stock Titan
ChartWatch ASX scans: Brazilian Rare Earths, Echoiq, Weebit Nano, Anteris Technologies, Global X Semiconductor ETF - MSN
AVR - Finviz
Anteris Technologies Global Corp. Q1 2026 Earnings: EPS Misses Expectations as Stock RisesWeak Earnings Momentum - The Legal Advocate
Anteris launches $250m at-the-market program to fund structural heart push - TipRanks
Anteris Technologies Global Corp plans to issue up to $250 million in common stock through TD Cowen as the underwriter. - Bitget
Anteris Technologies Global Launches $250 Million ATM Offering Under Sales Agreement With TD Cowen - TradingView
Anteris (NASDAQ: AVR) launches $250M at-the-market share program - Stock Titan
Anteris Technologies (NASDAQ: AVR) establishes $250M ATM with TD Cowen - Stock Titan
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Pre-Revenue Biotech Posts Wider-Than-Expected Loss, Stock Rallies on Pipeline OptimismCash Flow Report - newsline.com
ChartWatch ASX Scans: Brazilian Rare Earths, Echoiq, Weebit Nano. Anteris Technologies, Global X Semiconductor ETF - Market Index
Anteris Technologies Global : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
Director Susan Knight reports initial insider status at Anteris (NASDAQ: AVR) - Stock Titan
Number of shareholders of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Stephen Denaro details indirect Anteris (AVR) share and option holdings - Stock Titan
Nantahala holds 6,143,154 shares of Anteris (AVR) as of 03/31/2026 - Stock Titan
AVR Maintained by Barclays -- Price Target Raised to $18.00 - GuruFocus
We Think Anteris Technologies Global (ASX:AVR) Can Afford To Drive Business Growth - simplywall.st
Anteris Technologies Global Corp. (AVR) Gets a Buy from TD Cowen - The Globe and Mail
Anteris Announces Results for the First Quarter of 2026 - Sahm
Anteris Technologies Adds Experienced Financial Leaders to Board - The Globe and Mail
TradingKey - TradingKey
Here's Why We're Not Too Worried About Anteris Technologies Global's (ASX:AVR) Cash Burn Situation - Yahoo Finance
How Should Investors Value Anteris Technologies Global Corp (AVR - GuruFocus
Anteris Technologies appoints two directors to board - Investing.com
Anteris Technologies appoints two directors to board By Investing.com - Investing.com South Africa
Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors - The Manila Times
Two experienced directors join Anteris as it advances DurAVR heart valve - Stock Titan
Anteris Technologies Reports Q1 2026 Results: $320M Raised and Key Milestones in PARADIGM Trial for DurAVR THV System - Minichart
Anteris Technologies Global Corp. Files Form 8-K for Nasdaq Listing and Company Details (May 12, 2026) - Minichart
Anteris Technologies Global adds Susan Knight and Stephen Denaro to board - Investing.com
Anteris Technologies Global Starts US PARADIGM Trial Enrolment - smallcaps.com.au
Anteris Technologies Posts Narrower Q1 Loss, Lower Net Sales - Moomoo
Why Market Is Bullish on Anteris Technologies (ASX:AVR) Today - Kalkine
Anteris adds seasoned finance leaders to board as structural heart push continues - TipRanks
Anteris Technologies Q1 2026 Results: DurAVR™ THV Trial Progresses, Cash Balance at $64.9 Million - geneonline.com
1.68%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):